title: A comparison of three stool tests for colorectal cancer screening.
abstract: The annual guaiac or immunochemical fecal occult blood test (FOBT) is one of the five colorectal cancer (CRC) screening regimens recommended by the American Cancer Society (Smith, Cokkinides, & Eyre, 2005). Stool-based deoxyribonucleic acid (DNA) testing for CRC is considered a promising technology (Smith, Cokkinides, & Eyre, 2003). Numerous features of three noninvasive stool tests for CRC are compared.
authors.affiliation: Department of Nursing, North Dakota State University, Fargo, ND, USA.
authors.forename: Beverly
authors.initials: B
authors.lastname: Greenwald
mesh_terms: D000359:Aftercare; D015982:Bias; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D003362:Cost-Benefit Analysis; D004273:DNA, Neoplasm / Q000032:analysis*; D005188:False Negative Reactions; D005189:False Positive Reactions; D006138:Guaiac / Q000191:economics / Q000592:standards*; D006801:Humans; D007120:Immunochemistry / Q000191:economics / Q000592:standards*; D007202:Indicators and Reagents / Q000191:economics / Q000592:standards*; D008403:Mass Screening / Q000191:economics / Q000379:methods* / Q000592:standards; D009017:Morbidity; D009780:Occult Blood; D010349:Patient Compliance; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013048:Specimen Handling / Q000191:economics / Q000379:methods / Q000592:standards; D015996:Survival Rate
chemical_list: D004273:DNA, Neoplasm; D007202:Indicators and Reagents; D006138:Guaiac